Fezan Mutlu

1.5k total citations
91 papers, 1.0k citations indexed

About

Fezan Mutlu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Fezan Mutlu has authored 91 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Fezan Mutlu's work include Ovarian function and disorders (6 papers), Heart rate and cardiovascular health (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). Fezan Mutlu is often cited by papers focused on Ovarian function and disorders (6 papers), Heart rate and cardiovascular health (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). Fezan Mutlu collaborates with scholars based in Türkiye, Serbia and United Kingdom. Fezan Mutlu's co-authors include Olga Meltem Akay, Zafer Gülbaş, Hikmet Hassa, Zerrin Cantürk, Zeki Üstüner, Didem Turgut Coşan, H. Mete Tanir, Hasan Veysi Güneş, İrfan Değirmenci and Ahu Soyocak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Fezan Mutlu

83 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fezan Mutlu Türkiye 18 141 136 114 112 105 91 1.0k
Niki Malliaraki Greece 24 70 0.5× 121 0.9× 139 1.2× 178 1.6× 61 0.6× 43 1.3k
Liyuan Han China 14 152 1.1× 212 1.6× 19 0.2× 128 1.1× 108 1.0× 39 1.2k
Erkan Cüre Türkiye 22 129 0.9× 246 1.8× 48 0.4× 82 0.7× 69 0.7× 102 1.4k
Mehmet Ağırbaşlı Türkiye 22 530 3.8× 121 0.9× 121 1.1× 134 1.2× 32 0.3× 84 1.5k
Carla Russo Italy 18 245 1.7× 194 1.4× 296 2.6× 116 1.0× 16 0.2× 53 1.4k
Egidio Celentano Italy 26 469 3.3× 275 2.0× 133 1.2× 196 1.8× 37 0.4× 83 2.1k
Xiaoqing Li China 18 61 0.4× 242 1.8× 21 0.2× 100 0.9× 43 0.4× 103 989
Mustafa Özbek Türkiye 23 196 1.4× 259 1.9× 25 0.2× 117 1.0× 120 1.1× 129 1.8k
İbrahim Sarı Türkiye 22 390 2.8× 164 1.2× 65 0.6× 122 1.1× 16 0.2× 97 1.5k
Murat Yüksel Türkiye 23 538 3.8× 131 1.0× 32 0.3× 71 0.6× 65 0.6× 78 1.6k

Countries citing papers authored by Fezan Mutlu

Since Specialization
Citations

This map shows the geographic impact of Fezan Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fezan Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fezan Mutlu more than expected).

Fields of papers citing papers by Fezan Mutlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fezan Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fezan Mutlu. The network helps show where Fezan Mutlu may publish in the future.

Co-authorship network of co-authors of Fezan Mutlu

This figure shows the co-authorship network connecting the top 25 collaborators of Fezan Mutlu. A scholar is included among the top collaborators of Fezan Mutlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fezan Mutlu. Fezan Mutlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Soyocak, Ahu, Didem Turgut Coşan, Merih Özgen, et al.. (2024). Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Turkish postmenopausal women with osteoporosis. Nucleosides Nucleotides & Nucleic Acids. 44(10). 783–792.
4.
Mutlu, Fezan, et al.. (2023). Does the levels of vitamin D correlate with the levels of vitamin B12 and ferritin in fibromyalgia?. Journal of Surgery and Medicine. 7(11). 732–735.
5.
6.
Mutlu, Fezan, et al.. (2021). Musculoskeletal symptoms and related factors in postacute COVID‐19 patients. International Journal of Clinical Practice. 75(11). e14734–e14734. 57 indexed citations
7.
Özgen, Merih, et al.. (2020). Anxiety, Depression and Quality of Life Levels of Mothers with Children with Cerebral Palsy. Güncel Pediatri. 18(1). 114–124. 3 indexed citations
8.
Özgen, Merih, et al.. (2020). Serebral Palsili Çocuğa Sahip Annelerin Anksıyete, Depresyon Ve Yaşam Kalitesi Düzeyleri. Güncel Pediatri. 18(1). 114–124. 1 indexed citations
9.
Mutlu, Fezan, et al.. (2020). Protective and curative role of vitamin D and hormones on the cadmium-induced inhibition of proliferation of human osteoblast cells. Journal of Basic and Clinical Physiology and Pharmacology. 32(5). 995–1000. 1 indexed citations
10.
Özgen, Merih, Didem Turgut Coşan, Ahu Soyocak, et al.. (2019). Is there any association between osteoporotic vertebral fracture and vitamin K epoxide reductase complex subunit-1 polymorphism in Turkish society? A pilot study. Clinics. 74. e739–e739. 2 indexed citations
11.
Bılır, Ayten, et al.. (2017). Evaluation of the effects of epidural bupivacaine on coagulation system by using thromboelastometry in women with gynecologic malignancies. European Journal of Gynaecological Oncology. 38(5). 760–763. 1 indexed citations
12.
Mutlu, Fezan, et al.. (2015). Prevalence of tobacco, alcohol and substance use among Eskisehir Osmangazi University students. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 309–318. 11 indexed citations
13.
Soyocak, Ahu, et al.. (2013). Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by tannic acid and resveratrol. AFRICAN JOURNAL OF BIOTECHNOLOGY. 12(12). 1431–1437. 1 indexed citations
14.
Çavuşoğlu, Yüksel, Şule Korkmaz, Selda Demırtaş, et al.. (2013). Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study. Journal of the American College of Cardiology. 62(18). C73–C73. 2 indexed citations
15.
Özgen, Merih, Didem Turgut Coşan, Ahu Soyocak, et al.. (2012). Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women. Clinics. 67(11). 1299–1302. 5 indexed citations
16.
Bayram, Banu, et al.. (2011). Plasminogen Activator Inhibitor Type-1 Gene 4G/5G Polymorphism and Polycystic Ovary Syndrome. Genetic Testing and Molecular Biomarkers. 15(7-8). 565–567. 5 indexed citations
17.
Akay, Olga Meltem, et al.. (2009). Retrospective Analysis of 111 Cases with Chronic Myeloproliferative Disorders: Clinical Features and Survival. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(1). 162–168. 1 indexed citations
18.
Mutlu, Fezan, Ünal Ayrancı, Kazım Özdamar, & Saadet Yazıcı. (2008). The Effects of Maternal Cigarette Smoking on Infant Anthropometric Measurements. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Hassa, Hikmet, et al.. (2008). Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Archives of Gynecology and Obstetrics. 279(6). 891–895. 50 indexed citations
20.
Mutlu, Fezan, Ünal Ayrancı, & Kazım Özdamar. (2006). 7 Cigarette Smoking Habits among Men and Women in Turkey: A Meta Regression Analysis. SHILAP Revista de lepidopterología. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026